Pharos iBio

388870 · KOSDAQ · ₩388870 · 파로스아이바이오

₩5,780▼ ₩110 (1.87%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
News · Edaily·

Paros IBio's 'Lasmotinib' preclinical results published in research journal

Predicted impact: Low· Actual: −3.0% vs sector, volume 0.8× normal (5 trading days)

Preclinical research publication; no financial size or regulatory milestone disclosed.

Also known as: Pharos iBio / 파로스아이바이오 / 388870 / KRX:388870

Source: KRX statistical information